Invivoscribe Announces FDA Approval for Distribution of the LeukoStrat CDx FLT3 Mutation Assay as an IVD Kit in the United States

Most visited

1 year ago full article

share

SAN DIEGO, May 19, 2020 /PRNewswire/ — Invivoscribe to offer the LeukoStrat® CDx FLT3 Mutation Assay as an FDA approved kit with analysis software. In 2017, Invivoscribe’s LeukoStrat® CDx FLT3 Mutation Assay became the first FDA a ...Read More

130o

62%
Menu

Leave a Comment